NEW Our free Dividend Tracker is live — see what your stocks pay you
Add your stocks and see every dividend they pay you — dates, amounts, and reinvested shares.
Start Free »

Carl Zeiss Meditec AG CZMWF | OTC

$38.21 $0.80 | 2.14%
SIGNAL:Signal available — unlock to view |2026-09-29 |F&G 54 |RSI 57.6

Company Overview:

Market Cap: $3.30B
Trailing PE: 23x
FWD PE: —
Payout Ratio (TTM): 40.9%
52-Week Range: $26.42 - $55.75

10 Year CZMWF Performance Metrics:

Total Return (with DRIP): 12.7% (1.20% CAGR)
Total Return (no DRIP): 17.7% (1.64% CAGR)
Share Price: 4.2% (0.41% CAGR)
Yield on Cost (with DRIP): 1.86%
Total Invested: $10,000
Total Value (with DRIP): $11,269
Total Return $ (with DRIP): $1,269
Dividend Increase: -46.9% (-10.01% CAGR)
Dividend Yield (FWD): 1.65% ($0.63)
CZMWF 10-yr Total Return ($10K invested)
1M 3M 6M YTD 1Y 3Y 5Y 10Y
CZMWF Share Price
1M 3M 6M YTD 1Y 3Y 5Y 10Y All
CZMWF Price CAGR:1Y: -25.08%2Y: -30.40%5Y: -28.92%10Y: 0.41%
CZMWF Dividend Charts
CZMWF - Dividends
CZMWF Dividend CAGR:1Y: -1.69%2Y: -0.85%5Y: -10.01%10Y: 3.47%
CZMWF - Dividend Payout Ratio
CZMWF Dividend Payout Ratio CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
CZMWF - Dividend to Free Cash Flow Ratio
CZMWF Dividend to FCF Ratio CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

Unlock All Reports & Research Dividend Stocks like a BOSS!

Save 25% with annual plan (3 Months Free)
PRO
$171 ($14.25/mo) $102.60/yr ($8.55/mo)
7-day free trial
  • Unlimited Portfolio Tracker
  • Portfolio - Lots/Sales/Dividends
  • Portfolio Auto-DRIP
  • Buy/Sell Signals Dashboard
  • Stock Fundamentals
  • Compare Stocks Side-by-Side
  • Revenue & EPS Estimates
  • DCF Valuation Modeling
Try it free for 7 days
You save $125.40 (55%)
Most Popular
PREMIUM
$288 ($24/mo) $172.80/yr ($14.40/mo)
7-day free trial
  • Everything in Pro
  • YieldMax PNL Tracker
  • YieldMax NAV Erosion Alerts
  • YM ETFs Trend Signals
  • 9/21 EMA Trend Signals
  • Stocks Dashboard
Try it free for 7 days
You save $211.20 (55%)
ULTRA
$576 ($48/mo) $345.60/yr ($28.80/mo)
7-day free trial
  • Everything in Premium
  • 15min & 1hr Intraday Signals
  • Group & weekly ETF estimates
  • YouTuber Mode
  • Trades summary + CSV export
  • Priority data & support
Try it free for 7 days
You save $422.40 (55%)

CZMWF Fundamentals: Earnings, Revenue, Cash Flow, Ebitda, Cash/Debt, Shares Float, etc:

CZMWF - Revenue
CZMWF Revenue CAGR:1Y: 2.38%2Y: 2.14%5Y: 5.49%10Y: 8.12%
CZMWF - Earnings Per Share (EPS)
CZMWF EPS CAGR:1Y: 93.94%2Y: 29.78%5Y: -7.00%10Y: 10.31%
CZMWF - Net Income
CZMWF Net Income CAGR:1Y: 99.23%2Y: 26.98%5Y: -7.57%10Y: 10.77%
CZMWF - EBITDA
CZMWF EBITDA CAGR:1Y: 57.11%2Y: 14.23%5Y: -8.76%10Y: 8.25%
CZMWF - Free Cash Flow
CZMWF Free Cash Flow CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
CZMWF - Free Cash Flow / Share
CZMWF Free Cash Flow / Share CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
CZMWF - Operating Income
CZMWF Operating Income CAGR:1Y: 14.87%2Y: 5.86%5Y: -12.44%10Y: 7.67%
CZMWF - Gross Profit
CZMWF Gross Profit CAGR:1Y: 4.34%2Y: 1.49%5Y: 2.95%10Y: 8.19%
CZMWF - Shares Outstanding
CZMWF Shares Outstanding CAGR:1Y: -1.00%2Y: -1.93%5Y: -0.45%10Y: 0.46%
CZMWF - Share Buybacks
CZMWF Share Buybacks CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
CZMWF - Stock-Based Comp
CZMWF Stock-Based Comp CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
CZMWF - Expenses
CZMWF Expenses CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:

CZMWF - REVENUE: Actual + Estimates
CZMWF Actual Revenue CAGR:1Y: 2.38%2Y: 2.14%5Y: 5.49%10Y: 8.12%
CZMWF - EPS: Actual + Estimates
CZMWF Actual EPS CAGR:1Y: 93.94%2Y: 29.78%5Y: -7.00%10Y: 10.31%
CZMWF - NET INCOME: Actual + Estimates
CZMWF Actual Net Income CAGR:1Y: 99.23%2Y: 26.98%5Y: -7.57%10Y: 10.77%
CZMWF - EBITDA: Actual + Estimates
CZMWF Actual EBITDA CAGR:1Y: 57.11%2Y: 14.23%5Y: -8.76%10Y: 8.25%

Ratios, Profit Margins & Return on Capital:

CZMWF - Net Profit Margin
CZMWF Net Profit Margin CAGR:1Y: 89.53%2Y: 24.30%5Y: -12.38%10Y: 2.46%
CZMWF - Gross Profit Margin
CZMWF Gross Profit Margin CAGR:1Y: 1.92%2Y: -0.64%5Y: -2.40%10Y: 0.06%
CZMWF - Price to Earnings
CZMWF Price to Earnings CAGR:1Y: -75.92%2Y: -51.13%5Y: -25.09%10Y: -12.15%
CZMWF - Price To Sales Ratio
CZMWF Price To Sales Ratio CAGR:1Y: -54.84%2Y: -39.14%5Y: -34.31%10Y: -9.95%
CZMWF - Return on Capital Employed
CZMWF Return on Capital Employed CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
CZMWF - Return on Invested Capital
CZMWF Return on Invested Capital CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

Compare stocks side-by-side

CZMWF Dividends Info:

Annual Dividend: $0.63
Forward Yield: 1.65%
Ex-Dividend Date: 2026-03-30
Lifetime Dividends / Share: $7.48

CZMWF Dividend History: Dates, Payments & Yield list

Below is a schedule of all CZMWF dividend payments, ex-dates, share price on the day of the payment as well as the annualized yield & forward yield

Ex-Date Payment Date Amount Yield Forward Yield Price on Ex-Date
03/30/202603/31/2026$0.6302.24%2.24%$28.11
03/27/202603/30/2026$0.6342.27%2.26%$28.11
03/28/202503/31/2025$0.6450.94%0.94%$68.73
03/27/202503/31/2025$0.6450.94%0.94%$68.73
03/22/202403/25/2024$1.1950.95%0.93%$129.04
03/23/202303/27/2023$1.1950.8%0.8%$149.25
03/25/202004/01/2020$0.6500.76%0.76%$85.92
04/07/201604/14/2016$0.4331.34%1.34%$32.40
03/19/201503/26/2015$0.4351.64%1.64%$26.56
03/05/201403/12/2014$0.6182.12%2.12%$29.09
03/06/201303/13/2013$0.4005.49%5.49%$29.15

Projected Future Returns & Dividends for CZMWF

Based on past 10-year performance, here are CZMWF growth metrics:

Share price CAGR of +0.41%
Dividend CAGR of -0.25%

Using CZMWF CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:

CZMWF (DRIP)CZMWF - No DRIP
Current Price$38.21$38.21
Start Shares261.71261.71
Start Value$10,000$10,000
  
After 10 years:
Final Share Count306.76261.71
Dividends Payment$0.61$0.61
Annual Dividends$188$161
Yield on cost1.88%1.61%
Share Price$39.80$39.80
Total Dividends$1,754$1,630
Final Value$12,210$12,048

Estimated Future Value + Dividends - CZMWF

NOTE: Above numbers are our estimate based on CZMWF's Dividend and Price CAGR over past 10 years. These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.

We cannot guarantee that your actual returns will meet these estimates.

Get the best Dividend Stock Research Tools:

Save 25% with annual plan (3 Months Free)
PRO
$171 ($14.25/mo) $102.60/yr ($8.55/mo)
7-day free trial
  • Unlimited Portfolio Tracker
  • Portfolio - Lots/Sales/Dividends
  • Portfolio Auto-DRIP
  • Buy/Sell Signals Dashboard
  • Stock Fundamentals
  • Compare Stocks Side-by-Side
  • Revenue & EPS Estimates
  • DCF Valuation Modeling
Try it free for 7 days
You save $125.40 (55%)
Most Popular
PREMIUM
$288 ($24/mo) $172.80/yr ($14.40/mo)
7-day free trial
  • Everything in Pro
  • YieldMax PNL Tracker
  • YieldMax NAV Erosion Alerts
  • YM ETFs Trend Signals
  • 9/21 EMA Trend Signals
  • Stocks Dashboard
Try it free for 7 days
You save $211.20 (55%)
ULTRA
$576 ($48/mo) $345.60/yr ($28.80/mo)
7-day free trial
  • Everything in Premium
  • 15min & 1hr Intraday Signals
  • Group & weekly ETF estimates
  • YouTuber Mode
  • Trades summary + CSV export
  • Priority data & support
Try it free for 7 days
You save $422.40 (55%)

Company Info

Carl Zeiss Meditec AG (CZMWF) had its IPO on 2012-03-14, and is traded on OTC stock exchange.

Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, including slit lamps, refractometers, and tonometers; optical coherence tomography and fundus cameras for retina examination; functional glaucoma diagnostic devices (perimeters); surgical ophthalmology products comprising surgical microscopes, biometers, and phacoemulsification and vitrectomy equipment; intraocular lenses for cataract surgery; and systems and consumables for laser eye surgery that include the VISUMAX femtosecond laser, which enables minimally invasive correction of vision defects using lenticular extraction, as well as digital products for the storage, analysis, and sharing of clinical data. The Microsurgery segment provides products and solutions for minimally invasive surgical treatments, including surgical visualization, interoperative radiotherapy, interoperative pathology, special surgical instruments, and digital solutions, as well as the ZEISS Tumor Workflow, a cross-product workflow solution. It serves physicians in various fields and hospitals. The company was founded in 1846 and is headquartered in Jena, Germany. Carl Zeiss Meditec AG operates as a subsidiary of ZEISS Group.

CZMWF website: https://www.zeiss.com


Get Full Access to All Reports with DRIPCalc PRO

Save 25% with annual plan (3 Months Free)
PRO
$171 ($14.25/mo) $102.60/yr ($8.55/mo)
7-day free trial
  • Unlimited Portfolio Tracker
  • Portfolio - Lots/Sales/Dividends
  • Portfolio Auto-DRIP
  • Buy/Sell Signals Dashboard
  • Stock Fundamentals
  • Compare Stocks Side-by-Side
  • Revenue & EPS Estimates
  • DCF Valuation Modeling
Try it free for 7 days
You save $125.40 (55%)
Most Popular
PREMIUM
$288 ($24/mo) $172.80/yr ($14.40/mo)
7-day free trial
  • Everything in Pro
  • YieldMax PNL Tracker
  • YieldMax NAV Erosion Alerts
  • YM ETFs Trend Signals
  • 9/21 EMA Trend Signals
  • Stocks Dashboard
Try it free for 7 days
You save $211.20 (55%)
ULTRA
$576 ($48/mo) $345.60/yr ($28.80/mo)
7-day free trial
  • Everything in Premium
  • 15min & 1hr Intraday Signals
  • Group & weekly ETF estimates
  • YouTuber Mode
  • Trades summary + CSV export
  • Priority data & support
Try it free for 7 days
You save $422.40 (55%)
Loading signals…

DCF Model — CZMWF

Value from:
Pay up to today
—
vs current price $38.21
—
Cash flow & implied price by year

FCF is negative or missing for this company (common for banks) — the model discounts EPS instead.

EPS is negative or missing for this company — Simple mode uses free cash flow per share instead.

Free cash flow today
—
grows for the next years
Then mature
—
every future dollar counted back to today
Pile of today-dollars
—
÷ shares
Implied price path
YearFCFImplied price
Sensitivity — fair value: growth ↓ × target return →